Filing search / Lineage Cell Therapeutics, Inc. / "Long-term"

8-K

EX-99.1

LCTX Lineage Cell Therapeutics, Inc.

8 Aug 24

Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

4:10pm

related to Lineage’s cell therapy technology platform to support commercial manufacturing strategies. oPositive clinical data from long-term follow-up … Property and equipment, net Operating lease right-of-use assets Deposits and other long-term assets Goodwill Intangible assets, net TOTAL ASSETS LIABILITIES

424B5

LCTX Lineage Cell Therapeutics, Inc.

14 May 24

Prospectus supplement for primary offering

4:36pm

the safety and utility of a novel spinal cord delivery device in both subacute and chronic spinal cord injuries and continues to be evaluated in long-term follow … to broaden the application of our cell therapy platform and support long-term growth include a strategic collaboration we entered into with Eterna

8-K

EX-99.1

LCTX Lineage Cell Therapeutics, Inc.

9 May 24

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

4:10pm

with Genentech to Support Ongoing Development of the OpRegen® Program Long-Term Visual Benefits from a Single Administration with OpRegen Reported … clinical study in patients with GA secondary to AMD. oPositive clinical data from long-term follow-up of patients from the Phase 1/2a clinical study

424B5

e1qgx65

22 Mar 24

Prospectus supplement for primary offering

4:32pm

8-K

EX-1.1

kvaa swcql1oo0y

22 Mar 24

Entry into a Material Definitive Agreement

4:15pm

8-K

EX-99.1

dikvn8elfs1q7y

7 Mar 24

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

4:10pm

424B5

cuhtl

6 Feb 24

Prospectus supplement for primary offering

9:25am

8-K

EX-99.1

sujg 8t41y4zuv

9 Nov 23

Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

4:10pm

8-K

EX-99.1

dbltpt 8lo50fko

10 Aug 23

LINEAGE CELL THERAPEUTICS REPORTs SECOND QUARTER 2023 FINANCIAL

4:10pm

8-K

EX-99.1

xtm5yblgsn chpxz7

11 May 23

LINEAGE CELL THERAPEUTICS REPORTs FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

4:10pm